Eris Lifesciences is unique with 100% of its sales from domestic pharma market, unlike other Indian pharma companies. Over the past 5 years, its revenue has grown over 50% and net profit by ~300%. Its stock price has corrected by 25% over the past 12 months. Is it worth buying now at around Rs. 600 at PE ratio of around 30?
top of page
bottom of page